---
title: "Earnings Summary: Cardinal Health Q2"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274965545.md"
description: "Cardinal Health (NYSE:CAH) reported its Q2 earnings on February 5, 2026, beating estimates by 10.97% with an EPS of $2.63 compared to the expected $2.37. Revenue increased to $9.97 billion year-over-year. In the previous quarter, the company also exceeded EPS estimates, resulting in a 0.49% share price increase the following day. For Q1 2026, EPS was $2.55 against an estimate of $2.19, and revenue was $64.01 billion compared to an estimate of $59.18 billion."
datetime: "2026-02-05T11:46:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274965545.md)
  - [en](https://longbridge.com/en/news/274965545.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274965545.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274965545.md) | [繁體中文](https://longbridge.com/zh-HK/news/274965545.md)


# Earnings Summary: Cardinal Health Q2

The Q2 earnings report for **Cardinal Health** (NYSE:CAH) was released on Thursday, February 5, 2026 at 06:45 AM.

Here's what investors need to know about the latest announcement.

### Earnings

Cardinal Health beat estimated earnings by 10.97%, reporting an EPS of $2.63 versus an estimate of $2.37.

Revenue was up $9.97 billion from the same period last year.

### Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.36, leading to a 0.49% increase share price change the next day.

Here's a look at Cardinal Health's past performance:

**Quarter**

**Q1 2026**

**Q4 2025**

**Q3 2025**

**Q2 2025**

**EPS Estimate**

2.19

2.03

2.17

1.76

**EPS Actual**

2.55

2.08

2.35

1.93

**Revenue Estimate**

59.18B

60.82B

55.35B

54.97B

**Revenue Actual**

64.01B

60.16B

54.88B

55.26B

To track all earnings releases for Cardinal Health visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [State Street® SPDR® S&P® PhrmctlsETF (XPH.US)](https://longbridge.com/en/quote/XPH.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [VanEck Pharmaceutical ETF (PPH.US)](https://longbridge.com/en/quote/PPH.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [Cardinal Health, Inc. (CAH.US)](https://longbridge.com/en/quote/CAH.US.md)
- [Invesco Pharmaceuticals ETF (PJP.US)](https://longbridge.com/en/quote/PJP.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [Did Cardinal Health's (CAH) New Chair and Urology Deal Just Reframe Its Healthcare Partnership Strategy?](https://longbridge.com/en/news/281035253.md)
- [Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 | CAH Stock News](https://longbridge.com/en/news/280300180.md)
- [ZEO ScientifiX named official regenerative medicine education partner for A4M at Longevity SpringFest](https://longbridge.com/en/news/281186422.md)
- [Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake](https://longbridge.com/en/news/281582214.md)
- [Heirloom Wealth Management Buys 16,650 Shares of Intuitive Surgical, Inc. $ISRG](https://longbridge.com/en/news/281345776.md)